VANGUARD GROUP INC 13D and 13G filings for Beam Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 4:11 pm Sale | 2026-03-13 | 13G | BEAM THERAPEUTICS INC BEAM | VANGUARD GROUP INC | 0 0.000% | -7,164,843 (Position Closed) | Filing |
| 2024-02-13 5:00 pm Purchase | 2023-12-29 | 13G | BEAM THERAPEUTICS INC BEAM | VANGUARD GROUP INC | 7,164,843 8.790% | 891,213 (+14.21%) | Filing |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | BEAM THERAPEUTICS INC BEAM | VANGUARD GROUP INC | 6,273,630 8.900% | 1,576,365 (+33.56%) | Filing |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | BEAM THERAPEUTICS INC BEAM | VANGUARD GROUP INC | 4,697,265 6.890% | 4,697,265 (New Position) | Filing |